VENOUS THROMBOEMBOLISM (VTE)

This study is testing if a special exercise and education program can help people recover better after a serious lung clot (pulmonary embolism). Many patients still feel tired, short of breath, and have a poor quality of life months later, even with standard blood thinner medicat…

This study is testing a new computer tool called the CLOVER score. It aims to help doctors figure out which patients with a serious blood clot (VTE) are most likely to have an undetected cancer hiding in their body. The tool will be tested on 500 patients to see how well it predi…

This study is testing an experimental drug, REGN7508, to see if it can safely prevent dangerous blood clots in adults having elective total knee replacement surgery. It will compare the new drug against two standard blood clot prevention medications. The goal is to find a more ef…

This large study is testing whether a short, low-dose injection of a blood thinner (heparin) for 7-10 days after delivery can safely prevent dangerous blood clots in women at higher risk. It will compare the injection to no treatment in 9,200 postpartum women, tracking them for 9…

This study aims to understand if specific genetic mutations in a patient's lung cancer make them more likely to develop dangerous blood clots, known as venous thromboembolism (VTE). Researchers will follow 500 people with advanced non-small cell lung cancer (NSCLC) for six months…

This study aims to understand what factors increase the risk of dangerous blood clots after lung cancer surgery. Researchers will follow 900 patients for 30 days after their operation, collecting health data to identify warning signs. They will use computer models (machine learni…